How should legacy medical devices with older DHF files approach QMSR compliance?
Answered at 14:20 in #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru
How should legacy medical devices with older DHF files approach QMSR compliance?
FDA has stated it does not expect companies to go back into pre-QMSR files and add ISO references or remove DHF terminology. However, investigators may review records created before the effective date, and FDA recommends conducting a gap analysis of legacy designs still being marketed. The key is not rewriting files but examining the wiring—specifically, whether anything the field taught you in recent years made it back into the risk file. If not, that is a legacy documentation problem.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
FDA has stated it does not expect companies to go back into pre-QMSR files and add ISO references or remove DHF terminology.
Nikhil Mangali, Vice President of Quality at Capstone Medical · #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru · answer at 14:20
Key takeaways
- FDA has stated it does not expect companies to go back into pre-QMSR files and add ISO references or remove DHF terminology.
Quote to remember
“Your own risk documentation tells you that. Your own file is now the navigation instrument for an investigator.”
— Nikhil Mangali
The full answer · about 3 min
FDA has stated it does not expect companies to go back into pre-QMSR files and add ISO references or remove DHF terminology. However, investigators may review records created before the effective date, and FDA recommends conducting a gap analysis of legacy designs still being marketed. The key is not rewriting files but examining the wiring—specifically, whether anything the field taught you in recent years made it back into the risk file. If not, that is a legacy documentation problem.
Key facts
- QMSR effective for seven months at time of episode recording
- Proposed rule released three and a half years before QMSR implementation
- Risk management process must run through product realization under ISO 13485 Clause 7.3, not just at design validation
- FDA compliance program organizes inspection around six QMS areas plus four FDA-specific requirements
- July 2024: Nikhil Mangali promoted to Vice President of Quality at Capstone Medical
People, companies and topics mentioned
More answers from this episode
- 0:54What are the top 5 FDA citations from QMSR audits according to real inspection data?
- 3:00Why is risk management the most cited QMSR compliance violation?
- 5:15What specific supplier control issues are FDA citing under QMSR?
- 17:45What are the three layers of DHF to ISO 13485 mapping and what do most companies miss?
- 20:10What is the four-phase gap assessment process for QMSR compliance?